Income Statement CITIC Securities Company Limited

Equities

600030

CNE000001DB6

Investment Banking & Brokerage Services

End-of-day quote Shanghai S.E. Other stock markets 13/03/2026			5-day change	1st Jan Change
25.75 ^CNY	-0.69%		-2.57%	-10.31%

03-13	CITIC Securities Company Limited Approves the Election of WU Yonggao as the Non-Executive Director and Serve as A Member of Each of the Strategic Planning and ESG Committee and the Risk Management Committee, Effective from 13 March 2026	CI
03-13	Nsing Technologies Seeks Up to HK$1.03 Billion in Hong Kong IPO	MT

ad95f66316.yeMSEddBNoiIeA-yp4zoDqlhM1d2SdC_wU84TwDR1rU.s6dXeJM7cP-7HkP23eGwPvxYAzo-ML-Ihxp3PWrntPCsrFYmuBZSv7gyZA

Published financial data: CITIC SECURITIES COMPANY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Interest and Dividend Income, Total	40.41B	38.84B	38.66B	40.52B	52.43B
Interest Expense, Total	12.94B	15.24B	15.22B	17.58B	18.86B
Net Interest Income	27.47B	23.6B	23.44B	22.94B	33.57B
Brokerage Commission	-	-	37.95B	-	-
Trading and Principal Transactions	-	-	145M	-	-
Gain (Loss) on Sale of Investments, Total (Rev)	-6.39B	5.31B	-	3.57B	-6.02B
Other Revenues, Total	33.46B	47.49B	-	32.63B	32.52B
Revenues Before Provison For Loan Losses	54.54B	76.4B	61.53B	59.14B	60.07B
Provision For Loan Losses	711M	1.79B	-	-	-
Total Revenues	53.83B	74.61B	61.53B	59.14B	60.07B
Salaries And Other Employee Benefits	-	-	21.17B	-	-
Cost of Services Provided, Total	20.47B	28.24B	6.91B	29B	30.22B
Depreciation & Amortization - (IS) - (Collected)	-	-	458M	-	-
Provision for Bad Debts	435M	332M	-56.6M	-52.3M	34.73M
Other Operating Expenses	6.52B	12.47B	6.48B	5.32B	6.16B
Total Operating Expenses	27.43B	41.04B	34.97B	34.27B	36.41B
Operating Income	26.4B	33.57B	26.56B	24.88B	23.65B
Income (Loss) on Equity Invest.	-	-	673M	-	-
Currency Exchange Gains (Loss)	-329M	-138M	884M	535M	3.43B
Other Non Operating Income (Expenses)	-	-	1.63B	610M	-444M
EBT, Excl. Unusual Items	26.08B	33.43B	29.75B	26.02B	26.64B
Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-81.49M	-2.07B	-319M	-	-
Gain (Loss) on Sale of Investments	-5.43B	1.17B	-476M	-298M	1.59B
Gain (Loss) on Sale of Assets	66.08K	38.38M	-	564K	-3.72M
Asset Writedown	-91.98M	-365M	-2.93M	-125K	-20.98M
Insurance Settlements	-	-	-	-	215M
Other Unusual Items	2.73M	-304M	-	460M	-2.57M
EBT, Incl. Unusual Items	20.47B	31.89B	28.95B	26.19B	28.42B
Income Tax Expense	4.95B	7.89B	6.78B	5.65B	5.83B
Earnings From Continuing Operations	15.52B	24.01B	22.17B	20.54B	22.59B
Net Income to Company	15.52B	24.01B	22.17B	20.54B	22.59B
Minority Interest	-	-905M	-851M	-819M	-886M
Net Income - (IS)	15.52B	23.1B	21.32B	19.72B	21.7B
Preferred Dividend and Other Adjustments	-	158M	497M	525M	806M
Net Income to Common Incl Extra Items	15.52B	22.94B	20.82B	19.2B	20.9B
Net Income to Common Excl. Extra Items	15.52B	22.94B	20.82B	19.2B	20.9B
Per Share Items
Net EPS - Basic	1.21	1.77	1.42	1.3	1.41
Basic EPS - Continuing Operations	1.21	1.77	1.42	1.3	1.41
Basic Weighted Average Shares Outstanding	12.86B	12.93B	14.71B	14.82B	14.82B
Net EPS - Diluted	1.16	1.77	1.42	1.3	1.41
Diluted EPS - Continuing Operations	1.16	1.77	1.42	1.3	1.41
Diluted Weighted Average Shares Outstanding	12.86B	12.93B	14.71B	14.82B	14.82B
Normalized Basic EPS	1.27	1.55	1.21	1.04	1.06
Normalized Diluted EPS	1.27	1.55	1.21	1.04	1.06
Dividend Per Share	0.4	0.54	0.49	0.48	0.52
Payout Ratio	88.43	52.34	72.79	70.03	82.8
American Depositary Receipts Ratio (ADR)	10	10	10	10	10
Supplemental Items
Total Revenues (As Reported)	54.38B	76.52B	85.94B	60.07B	63.79B
Effective Tax Rate - (Ratio)	24.2	24.73	23.42	21.56	20.51
Current Domestic Taxes	8.66B	7.5B	-	-	-
Total Current Taxes	8.66B	7.5B	8.54B	4.3B	6.98B
Total Deferred Taxes	-3.7B	390M	-1.76B	1.34B	-1.15B
Normalized Net Income	16.3B	19.99B	17.74B	15.45B	15.76B
Non-Cash Pension Expense	20.81M	2.31M	-	4.77M	11.55M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	75.44B	84.99B	112B	303B	371B
Cash & Securities Segregated	158B	195B	-	-	-
Securities Purchased Under Agreements To Resell	39.23B	46.39B	31.48B	62.21B	44.27B
Accounts Receivable, Total	139B	146B	16.49B	145B	170B
Other Receivables	19.57B	19.92B	29.28B	34.96B	36.14B
Gross Property Plant And Equipment	14.83B	15.68B	17.27B	19.18B	17.06B
Accumulated Depreciation	-5.53B	-5.99B	-7.05B	-7.98B	-6.62B
Net Property Plant And Equipment	9.3B	9.69B	10.22B	11.2B	10.44B
Goodwill	10.78B	8.68B	8.43B	8.44B	8.45B
Other Intangibles, Total	2.86B	3.59B	3.42B	3.35B	3.32B
Investment In Debt and Equity Securities	26.32B	39.65B	103B	51.2B	123B
Trading Asset Securities, Total	304B	386B	535B	658B	740B
Other Current Assets, Total	202B	289B	367B	118B	137B
Deferred Tax Assets Long-Term (Collected)	9.66B	9.49B	11.26B	6.69B	7.76B
Deferred Charges Long-Term	274M	230M	77.01M	359M	440M
Other Long-Term Assets, Total	56.42B	40.78B	80.27B	51.95B	59B
Total Assets	1,053B	1,279B	1,308B	1,453B	1,711B
Liabilities
Accounts Payable, Total	24.17B	38.46B	297B	32.07B	40.28B
Accrued Expenses, Total	240B	297B	49.11B	336B	412B
Short-Term Borrowings	264B	291B	292B	380B	501B
Current Portion of Long-Term Debt	-	-	96.63B	-	-
Current Portion of Leases	494M	542M	564M	-	-
Long-Term Debt	184B	233B	97.07B	198B	188B
Long-Term Leases	1.21B	1.34B	1.41B	2.43B	2.26B
Current Income Taxes Payable	6.24B	3.86B	4.06B	1.48B	2.95B
Unearned Revenue, Current	-	-	24.95M	24.14M	74.61M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	137B	190B	198B	224B	260B
Unearned Revenue Non Current	3.2B	1.15B	-	942M	926M
Pension & Other Post Retirement Benefits	171M	244M	-	294M	-
Deferred Tax Liability Non-Current	3.18B	3.19B	3.18B	170M	362M
Other Non Current Liabilities	3.72B	5.49B	10.42B	3.47B	3.59B
Total Liabilities	867B	1,065B	1,050B	1,179B	1,412B
Common Stock, Total	12.93B	12.93B	14.82B	14.82B	14.82B
Additional Paid In Capital	65.63B	65.63B	-	90.82B	-
Retained Earnings	103B	121B	133B	145B	155B
Comprehensive Income and Other	317M	10.01B	105B	17.85B	123B
Total Common Equity	182B	209B	253B	269B	293B
Minority Interest	4.17B	4.64B	5.25B	5.36B	5.66B
Total Equity	186B	214B	258B	274B	299B
Total Liabilities And Equity	1,053B	1,279B	1,308B	1,453B	1,711B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	12.93B	12.93B	14.82B	14.82B	14.82B
ECS Total Common Shares Outstanding	12.93B	12.93B	14.82B	14.82B	14.82B
Book Value / Share	14.06	15.35	17.08	17.01	17.7
Tangible Book Value	168B	197B	241B	257B	281B
Tangible Book Value Per Share	13	14.4	16.28	16.21	16.91
Total Debt	450B	526B	488B	581B	692B
Net Debt	-127B	-187B	-191B	-442B	-463B
Equity Method Investments, Total	8.88B	9.13B	9.65B	9.65B	9.61B
Full Time Employees	19.01K	23.7K	25.74K	26.82K	26.78K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	15.52B	23.1B	21.32B	19.72B	21.7B
Depreciation, Depletion & Amortization	1.21B	1.27B	1.35B	1.57B	1.73B
Amortization of Goodwill and Intangible Assets - (CF)	42.04M	183M	284M	141M	71.32M
Total Depreciation, Depletion & Amortization	1.25B	1.45B	1.63B	1.71B	1.8B
Amortization of Deferred Charges, Total	355M	177M	104M	262M	321M
(Gain) Loss On Sale of Asset - (CF)	75.64M	-38.69M	-924K	-633K	-206M
(Gain) Loss on Sale of Investments - (CF)	6.74B	-11.23B	13.38B	-6.64B	5.59B
Total Asset Writedown	274M	2.66B	322M	125K	20.98M
Provision for Credit Losses	711M	1.79B	-	-	444M
(Income) Loss On Equity Investments - (CF)	-	-	-673M	-	-
Provision and Write-off of Bad Debts	334M	110M	-698M	-52.3M	34.73M
Change in Trading Asset Securities	-49.26B	-118B	-9.75B	-92.27B	-19.44B
Change in Accounts Receivable	-90.3B	-72.69B	-	-74.55B	-53.43B
Change In Inventories	-838M	2.48B	-	-720M	-293M
Change in Accounts Payable	210B	189B	-	105B	220B
Change In Deferred Taxes	-3.46B	396M	-	1.62B	-1.06B
Change in Other Net Operating Assets (Collected)	-	-	25.27B	-	-
Other Operating Activities	10.76B	9.6B	4.35B	5.48B	-3.14B
Cash from Operations	102B	28.46B	55.26B	-40.84B	173B
Capital Expenditure	-609M	-720M	-1.3B	-1.58B	-1.29B
Sale of Property, Plant, and Equipment	-	-	-	-	689M
Cash Acquisitions	13.73B	-	-	-	-
Divestitures	9.65M	15.42M	-	-	-
Investment in Marketable and Equity Securities, Total	-21.67B	-7.64B	481M	-16.64B	-73.86B
Other Investing Activities, Total	1.68B	1.43B	31.47M	25.03M	203M
Cash from Investing	-6.86B	-6.92B	-792M	-18.2B	-74.26B
Long-Term Debt Issued, Total	257B	130B	77.91B	342B	367B
Total Debt Issued	257B	130B	77.91B	342B	367B
Long-Term Debt Repaid, Total	-227B	-118B	-133B	-281B	-377B
Total Debt Repaid	-227B	-118B	-133B	-281B	-377B
Issuance of Common Stock	-	-	30.16B	-	14B
Common Dividends Paid	-13.72B	-12.09B	-15.52B	-13.81B	-17.97B
Common & Preferred Stock Dividends Paid	-13.72B	-12.09B	-15.52B	-13.81B	-17.97B
Other Financing Activities, Total	-4.46B	9.84B	-1.21B	1.22B	-1.48B
Cash from Financing	12B	9.71B	-41.86B	48.28B	-15.36B
Foreign Exchange Rate Adjustments	-1.93B	-1.59B	557M	399M	245M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	105B	29.67B	13.16B	-10.35B	83.18B
Supplemental Items
Cash Interest Paid	12.21B	15.5B	-	19.55B	23.37B
Cash Income Tax Paid (Refund)	7.23B	13.4B	8.36B	10.95B	7.72B
Net Debt Issued / Repaid	30.18B	11.96B	-55.29B	60.87B	-9.91B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	1.68	2.06	1.71	1.49	1.43
Return On Equity %	8.83	12.01	9.39	7.71	7.88
Return on Common Equity	9.04	11.74	9.01	7.36	7.44
Margin Analysis
Gross Profit Margin %	62.43	62.72	89.93	52.28	51.79
SG&A Margin	0.45	0.57	35.58	1.31	2.09
Income From Continuing Operations Margin %	28.82	32.18	36.03	34.73	37.61
Net Income Margin %	28.82	30.96	34.64	33.34	36.13
Net Avail. For Common Margin %	28.82	30.75	33.84	32.46	34.79
Normalized Net Income Margin	30.28	26.79	28.83	26.11	26.24
Asset Turnover
Asset Turnover	0.06	0.06	0.05	0.04	0.04
Short Term Liquidity
Current Ratio	1.39	1.42	1.16	1.36	1.23
Quick Ratio	1.09	1.07	0.77	1.23	1.12
Operating Cash Flow to Current Liabilities	0.15	0.03	0.06	-0.04	0.14
Long Term Solvency
Total Debt/Equity	241.82	245.89	188.79	211.78	231.46
Total Debt / Total Capital	70.75	71.09	65.37	67.93	69.83
LT Debt/Equity	99.45	109.39	38.12	73.06	63.8
Long-Term Debt / Total Capital	29.09	31.63	13.2	23.43	19.25
Total Liabilities / Total Assets	82.35	83.28	80.25	81.13	82.54
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	26.98	38.6	-11.53	-7.41	1.56
Gross Profit, 1 Yr. Growth %	34.59	39.16	-12.25	-13.51	0.59
Earnings From Cont. Operations, 1 Yr. Growth %	22.68	54.71	-7.65	-7.35	9.98
Net Income, 1 Yr. Growth %	22.68	55.01	-7.72	-7.49	10.06
Normalized Net Income, 1 Yr. Growth %	40.89	28.47	-13.74	-10.59	2.06
Diluted EPS Before Extra, 1 Yr. Growth %	14.85	52.74	-16.1	-8.47	8.86
Common Equity, 1 Yr. Growth %	12.43	15.11	21.01	6.21	9.03
Total Assets, 1 Yr. Growth %	33	21.44	2.32	11.06	17.71
Tangible Book Value, 1 Yr. Growth %	13.16	17.15	22.53	6.54	9.45
Cash From Operations, 1 Yr. Growth %	363.34	-72.05	901.64	-152.01	-522.57
Capital Expenditures, 1 Yr. Growth %	42.15	18.13	81.18	21.15	-18.13
Dividend Per Share, 1 Yr. Growth %	-20	35	-9.26	-3.06	9.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.84	32.66	6.91	-7.79	-3.03
Gross Profit, 2 Yr. CAGR %	24.24	36.89	28.29	-29.98	-6.72
Earnings From Cont. Operations, 2 Yr. CAGR %	25.34	37.76	19.53	-7.5	0.94
Net Income, 2 Yr. CAGR %	28.55	35.14	19.6	-7.6	0.9
Normalized Net Income, 2 Yr. CAGR %	52.92	31.45	6.79	-13.34	-4.47
Diluted EPS Before Extra, 2 Yr. CAGR %	22.74	32.38	10.51	-12.37	-0.18
Common Equity, 2 Yr. CAGR %	8.93	13.76	18.02	13.37	7.61
Total Assets, 2 Yr. CAGR %	26.97	27.08	11.47	6.61	14.34
Tangible Book Value, 2 Yr. CAGR %	9.82	15.14	19.81	14.26	7.99
Cash From Operations, 2 Yr. CAGR %	32.9	13.8	-26.33	172.07	48.24
Capital Expenditures, 2 Yr. CAGR %	15.27	29.59	46.3	48.15	-0.41
Dividend Per Share, 2 Yr. CAGR %	6.9	3.92	10.68	-6.21	3.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.91	27.19	13.22	3.19	-4.77
Gross Profit, 3 Yr. CAGR %	7.55	29.05	30.38	-2.75	-20.99
Earnings From Cont. Operations, 3 Yr. CAGR %	9.01	34.45	20.57	9.8	-2.01
Net Income, 3 Yr. CAGR %	10.72	34.99	19.01	9.79	-2.06
Normalized Net Income, 3 Yr. CAGR %	16.24	42.08	15.32	-0.24	-8.49
Diluted EPS Before Extra, 3 Yr. CAGR %	7.26	31.98	11.9	3.78	-5.8
Common Equity, 3 Yr. CAGR %	6.65	10.95	16.13	13.95	11.9
Total Assets, 3 Yr. CAGR %	18.95	25.1	18.23	11.34	10.19
Tangible Book Value, 3 Yr. CAGR %	7.3	12.21	17.55	15.21	12.63
Cash From Operations, 3 Yr. CAGR %	-0.76	-20.97	35.98	-26.26	215.08
Capital Expenditures, 3 Yr. CAGR %	11.21	16.21	44.9	37.38	21.58
Dividend Per Share, 3 Yr. CAGR %	0	15.55	-0.67	5.9	-1.25
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.69	14.62	7.51	10.28	7.22
Gross Profit, 5 Yr. CAGR %	-1.87	16.11	15.42	7.27	4.49
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.29	16.93	13.1	15.77	12.3
Net Income, 5 Yr. CAGR %	-4.76	17.38	13.27	16	11.4
Normalized Net Income, 5 Yr. CAGR %	-2.04	16.38	11.33	17.25	6.39
Diluted EPS Before Extra, 5 Yr. CAGR %	-7.45	15.65	8.52	10.96	6.9
Common Equity, 5 Yr. CAGR %	5.48	7.95	11.06	11.91	12.64
Total Assets, 5 Yr. CAGR %	11.31	16.44	15.9	17.35	16.66
Tangible Book Value, 5 Yr. CAGR %	6.12	8.92	12.14	13.02	13.63
Cash From Operations, 5 Yr. CAGR %	3.38	-10.44	-11.91	-6.66	51.01
Capital Expenditures, 5 Yr. CAGR %	-32.31	3.8	24.1	28.07	24.72
Dividend Per Share, 5 Yr. CAGR %	-4.36	9.06	4.14	6.3	0.79